Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Hispano Química, S.A.: El proyecto Eureka EU-25
Köllermeier, T.; Roure, JuanCaso P-758Servicios y operacionesH.Q. is a medium size company in specialty chemicals for a variety of applications. One of the industrial segments in which H.Q. is leading is that of the chemistry for tanning and finishing leather. Since chrome-based tanning has some polluting consequences, H.Q. engaged in a research project to develope non-polluting alternative chemicals. H.Q. approached this project in partnership with important European tanneries and applied to the Eureka pr...Desde 8,20 €
-
Hispano Quimica, S.A.: Eureka Project EU-25
Köllermeier, T.; Roure, JuanCaso P-758-EServicios y operacionesDesde 8,20 €
-
North Goes East
Retsinas, Nicolas P.; Beyersdorfer, Daniela; Corsi, ElenaCaso HBS-208136-EFinanzasIn August 2006, Magnus Lofgren and Robert Provine, managing directors and co-founders of the "North Real Estate Opportunities Fund," need to decide which real estate investment the Fund should pursue as its first project. The Fund's target region, Central and Eastern Europe, was changing rapidly and returns in some of the more developed regions started to resemble those generated in Western Europe. Yet, the two partners had managed to identify se...Desde 8,20 €
-
Innovation and Growth at Actelion Ltd.
Pisano, Gary P.; Beyersdorfer, Daniela; Dittrich, RuthCaso HBS-611065-ELiderazgo y Dirección de personasIn late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on their orphan indication drug Tracleer, which Actelion sold and market...Desde 8,20 €